Zenith Capital Corp.
ZHCLF
$0.0001
-$0.0999-99.90%
| Weiss Ratings | ZHCLF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D | |||
| Reward Grade | E | |||
| Rating Factors | ZHCLF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Fair | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Weak | |||
| Total Return Index | Very Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | ZHCLF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 37,601.02 | |||
| Price History | ZHCLF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -99.91% | |||
| 30-Day Total Return | 0.00% | |||
| 60-Day Total Return | -99.90% | |||
| 90-Day Total Return | -99.88% | |||
| Year to Date Total Return | -99.80% | |||
| 1-Year Total Return | -99.93% | |||
| 2-Year Total Return | -99.95% | |||
| 3-Year Total Return | -99.92% | |||
| 5-Year Total Return | -- | |||
| 52-Week High % Change | -80.00% | |||
| 52-Week Low % Change | 4,999,900.00% | |||
| Price | ZHCLF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $0.25 | |||
| 52-Week Low Price | $0.00 | |||
| 52-Week Low Price (Date) | Sep 12, 2024 | |||
| 52-Week High Price (Date) | Apr 30, 2024 | |||
| Valuation | ZHCLF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 7.63M | |||
| Enterprise Value | 20.78M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -0.05 | |||
| Earnings Per Share Growth | -55.00% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | -- | |||
| Price/Book (Q) | -0.33 | |||
| Enterprise Value/Revenue (TTM) | -- | |||
| Price | $0.00 | |||
| Enterprise Value/EBITDA (TTM) | -3.64 | |||
| Enterprise Value/EBIT | -3.57 | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | ZHCLF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 152.56M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | ZHCLF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 587 390 7865 | |||
| Address | 4820 Richard Road SW Calgary, AB T3E 6L1 | |||
| Website | www.zenithepigenetics.com | |||
| Country | Canada | |||
| Year Founded | 2013 | |||
| Profitability | ZHCLF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -- | |||
| Profit Margin | -- | |||
| Management Effectiveness | ZHCLF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -52.54% | |||
| Return on Equity | -- | |||
| Income Statement | ZHCLF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | -- | |||
| Total Revenue (TTM) | -- | |||
| Revenue Per Share | -- | |||
| Gross Profit (TTM) | -- | |||
| EBITDA (TTM) | -5.71M | |||
| EBIT (TTM) | -5.82M | |||
| Net Income (TTM) | -7.68M | |||
| Net Income Avl. to Common (TTM) | -7.68M | |||
| Total Revenue Growth (Q YOY) | -- | |||
| Earnings Growth (Q YOY) | 43.50% | |||
| EPS Diluted (TTM) | -0.05 | |||
| EPS Diluted Growth (Q YOY) | 43.48% | |||
| Balance Sheet | ZHCLF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 29.00K | |||
| Cash Per Share (Q) | $0.00 | |||
| Total Current Assets (Q) | 7.48M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | -23.18M | |||
| Current Ratio (Q) | 0.461 | |||
| Book Value Per Share (Q) | -$0.15 | |||
| Total Assets (Q) | 9.33M | |||
| Total Current Liabilities (Q) | 16.22M | |||
| Total Debt (Q) | 13.18M | |||
| Total Liabilities (Q) | 32.51M | |||
| Total Common Equity (Q) | -23.18M | |||
| Cash Flow | ZHCLF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -6.00M | |||
| Cash from Financing (TTM) | 7.55M | |||
| Net Change in Cash (TTM) | -65.00K | |||
| Levered Free Cash Flow (TTM) | -5.97M | |||
| Cash from Operations (TTM) | -1.62M | |||
